- Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
-
Mabuchi S, Sugiyama T, Kimura T
- KMID: 2363325
- J Gynecol Oncol.
- 2016 May;27(3):e31.
- doi: 10.3802/jgo.2016.27.e31
Clear cell carcinoma (CCC) of the ovary is known to show poorer sensitivity to chemotherapeutic agents and to be associated with a worse prognosis than the more common serous adenocarcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Major clinical research advances in gynecologic cancer in 2014
-
Suh DH, Lee KH, Kim K, Kang S, Kim JW
- KMID: 2160800
- J Gynecol Oncol.
- 2015 Apr;26(2):156-167.
- doi: 10.3802/jgo.2015.26.2.156
In 2014, 9 topics were selected as major advances in clinical research for gynecologic oncology: 2 each in cervical and corpus cancer, 4 in ovarian cancer, and 1 in breast... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer
-
Kang S, Ju W, Kim JW, Park NH, Song YS, Kim SC, Park SY, Kang SB, Lee HP
- KMID: 1094158
- Exp Mol Med.
- 2006 Jun;38(3):320-324.
ERCC1 is a DNA repair gene and has been associated with resistance to DNA damaging agents. In this study we hypothesized that a polymorphism of ERCC1 Asn118Asn (C->T) might affect... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas
-
Miyamoto M, Takano M, Aoyama T, Soyama H, Yoshikawa , Tsuda H, Furuya K
- KMID: 2413444
- J Gynecol Oncol.
- 2017 May;28(3):e33.
- doi: 10.3802/jgo.2017.28.e33
OBJECTIVE: Ovarian clear cell carcinoma (CCC) is one of histological subtypes showing poor prognosis due to chemoresistance. The association of autophagy-related proteins and clinical implementation in CCC has not been... -
- CITED
-
- Close
- SHARE
-
- Close
- Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer
-
Zhu X, Lang J
- KMID: 2413224
- J Gynecol Oncol.
- 2017 Sep;28(5):e64.
- doi: 10.3802/jgo.2017.28.e64
Programmed death-1 (PD-1) and its ligand are part of the immune checkpoint pathway that down-regulates effector T cells in immune response, thereby causing immune suppression. The PD-1/programmed death-ligand 1 (PD-L1)... -
- CITED
-
- Close
- SHARE
-
- Close
- Port-Site Metastases and Chimney Effect of B-Ultrasound-Guided and Laparoscopically-Assisted Hyperthermic Intraperitoneal Perfusion Chemotherapy
-
Ba MC, Long H, Zhang XL, Gong YF, Yan ZF, Wang S, Tang YQ, Cui SZ
- KMID: 2419105
- Yonsei Med J.
- 2017 May;58(3):497-504.
- doi: 10.3349/ymj.2017.58.3.497
PURPOSE: COâ‚‚ leakage along the trocar (chimney effect) has been proposed to be an important factor underlying port-site metastasis after laparoscopic surgery. This study aimed to test this hypothesis by... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer
-
Park JY, Heo EJ, Lee JW, Lee YY, Kim TJ, Kim BG, Bae DS
- KMID: 2360250
- J Gynecol Oncol.
- 2016 Mar;27(2):e20.
- doi: 10.3802/jgo.2016.27.e20
OBJECTIVE: Fertility-sparing surgery (FSS) is becoming an important technique in the surgical management of young women with early-stage epithelial ovarian cancer (EOC). We retrospectively evaluated the outcome of laparoscopic FSS... -
- CITED
-
- Close
- SHARE
-
- Close
- Major clinical research advances in gynecologic cancer in 2013
-
Suh DH, Kim JW, Kang S, Kim HJ, Lee KH
- KMID: 2130105
- J Gynecol Oncol.
- 2014 Jul;25(3):236-248.
- doi: 10.3802/jgo.2014.25.3.236
In 2013, 10 topics were selected for major clinical research advances in gynecologic oncology; these included three topics regarding cervical cancer, three regarding ovarian cancer, two regarding endometrial cancer, and... -
- CITED
-
- Close
- SHARE
-
- Close
- 14-3-3ζ Overexpression is Associated with Poor Prognosis in Ovarian Cancer
-
Kim HJ, Sung SH, Kim CY, Bae MK, Cho MS, Kim YH, Kim SC, Ju W
- KMID: 2418848
- Yonsei Med J.
- 2018 Jan;59(1):51-56.
- doi: 10.3349/ymj.2018.59.1.51
PURPOSE: 14-3-3ζ regulates cell signaling, cell cycle progression, and apoptosis, and its overexpression is associated with disease recurrence and poor clinical outcomes in some solid tumors. However, its clinicopathological role... -
- CITED
-
- Close
- SHARE
-
- Close
